News
11-09-2023, 08:54 PM
Patients with HER2-positive breast cancer that has started to spread to other parts of the body survive for longer if they are treated with a new drug called pyrotinib, according to results from the longest follow-up of the PHOEBE randomized clinical trial in China.
More... (https://www.news-medical.net/news/20231108/Patients-with-advanced-HER2-positive-breast-cancer-live-longer-if-treated-with-pyrotinib-trial-shows.aspx)
More... (https://www.news-medical.net/news/20231108/Patients-with-advanced-HER2-positive-breast-cancer-live-longer-if-treated-with-pyrotinib-trial-shows.aspx)